Investments
28Portfolio Exits
11
Want to inform investors similar to Rockmore Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Rockmore Capital Investments
28 Investments
Rockmore Capital has made 28 investments. Their latest investment was in Cascadian Therapeutics as part of their PIPE on February 2, 2011.
Rockmore Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
2/11/2011 | PIPE | Cascadian Therapeutics | $0.15M | Yes | Atoll Asset Management, AXA, Bristol Capital Advisors, Cantara, Cowen, Dafna Capital Management, Deerfield Management, Downsview Capital, Evolution Capital Management, Global Capital Partners, Heights Capital Management, Highbridge Capital Management, Hudson Bay Capital Management, Iroquois Capital Group, JGB Management, Paramount BioCapital Asset Management, RG Capital, Rockmore Capital, Tail Wind Fund, and Undisclosed Venture Investors | |
12/12/2008 | Unattributed VC - II | Betawave | $22.5M | Yes | ||
6/23/2008 | PIPE - II | Genta | $20M | Yes | Arcus Ventures, Baker Brothers Investments, Bristol Capital Advisors, Downsview Capital, Enable Capital Management, FGS Advisors, Highbridge Capital Management, Iroquois Capital Group, Perceptive Advisors, RA Capital Management, RG Capital, Risk Reward Capital Management, Rockmore Capital, Rodman & Renshaw, and Tang Capital Management | |
6/20/2008 | PIPE | |||||
5/16/2008 | PIPE |
Date | 2/11/2011 | 12/12/2008 | 6/23/2008 | 6/20/2008 | 5/16/2008 |
|---|---|---|---|---|---|
Round | PIPE | Unattributed VC - II | PIPE - II | PIPE | PIPE |
Company | Cascadian Therapeutics | Betawave | Genta | ||
Amount | $0.15M | $22.5M | $20M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | Atoll Asset Management, AXA, Bristol Capital Advisors, Cantara, Cowen, Dafna Capital Management, Deerfield Management, Downsview Capital, Evolution Capital Management, Global Capital Partners, Heights Capital Management, Highbridge Capital Management, Hudson Bay Capital Management, Iroquois Capital Group, JGB Management, Paramount BioCapital Asset Management, RG Capital, Rockmore Capital, Tail Wind Fund, and Undisclosed Venture Investors | Arcus Ventures, Baker Brothers Investments, Bristol Capital Advisors, Downsview Capital, Enable Capital Management, FGS Advisors, Highbridge Capital Management, Iroquois Capital Group, Perceptive Advisors, RA Capital Management, RG Capital, Risk Reward Capital Management, Rockmore Capital, Rodman & Renshaw, and Tang Capital Management | |||
Sources |
Rockmore Capital Portfolio Exits
11 Portfolio Exits
Rockmore Capital has 11 portfolio exits. Their latest portfolio exit was Cascadian Therapeutics on March 09, 2018.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
3/9/2018 | Acq - P2P | 4 | |||
8/30/2013 | Acq - P2P | 1 | |||
8/26/2013 | Merger | 1 | |||
Date | 3/9/2018 | 8/30/2013 | 8/26/2013 | ||
|---|---|---|---|---|---|
Exit | Acq - P2P | Acq - P2P | Merger | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 4 | 1 | 1 |
Rockmore Capital Team
1 Team Member
Rockmore Capital has 1 team member, including current President, Bruce Bernstein.
Name | Work History | Title | Status |
|---|---|---|---|
Bruce Bernstein | Omicron Capital | President | Current |
Name | Bruce Bernstein |
|---|---|
Work History | Omicron Capital |
Title | President |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
